chr4-158572715-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_021634.4(RXFP1):āc.67C>Gā(p.Gln23Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000273 in 1,613,994 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_021634.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RXFP1 | NM_021634.4 | c.67C>G | p.Gln23Glu | missense_variant | 2/18 | ENST00000307765.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RXFP1 | ENST00000307765.10 | c.67C>G | p.Gln23Glu | missense_variant | 2/18 | 1 | NM_021634.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152154Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000200 AC: 5AN: 249556Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135392
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1461840Hom.: 0 Cov.: 31 AF XY: 0.0000193 AC XY: 14AN XY: 727214
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152154Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 74320
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 19, 2023 | The c.67C>G (p.Q23E) alteration is located in exon 2 (coding exon 2) of the RXFP1 gene. This alteration results from a C to G substitution at nucleotide position 67, causing the glutamine (Q) at amino acid position 23 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at